The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Palonosetron Hydrochloride
Palonosetron Hydrochloride · PALONOSETRON HYDROCHLORIDE .25 mg/5mL · Injection, Solution · Intravenous · Meitheal Pharmaceuticals Inc.
NDC 71288-0409-05 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$9.00
Reported to Texas DSHS · 2026 annual filing · Meitheal Pharmaceuticals, Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 25 MCG
$0.574
HCPCS J2469 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2025)
$186,806
20,071 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA215861
- TE code
- AP
- Approval date
- Aug 14, 2023
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Palonosetron Hydrochloride, Injection, .25 mg/5 mL (NDC 0703-4094-01)Nov 14, 2025
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Palonosetron Hydrochloride (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Eugia US LLC | PALONOSETRON HYDROCHLORIDE .25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Meitheal Pharmaceuticals Inc. | PALONOSETRON HYDROCHLORIDE .25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | PALONOSETRON HYDROCHLORIDE .25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | PALONOSETRON HYDROCHLORIDE .05 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Teva Parenteral Medicines, Inc. | PALONOSETRON HYDROCHLORIDE .25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Sandoz Inc | PALONOSETRON HYDROCHLORIDE .25 mg/5mL | Jul 15, 2026 | Aug 31, 2026 |
| Avenacy, Inc. | PALONOSETRON HYDROCHLORIDE .05 mg/mL | Jul 15, 2026 | Aug 5, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Palonosetron Hydrochloride — NDC 71288-0409-05," retrieved September 3, 2026, https://drugdashboards.com/drug/71288040905.
Free to cite with attribution — see how the data is put together.